Clinical Trial Update: Pediatric Subjects With Tinea Corporis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for pediatric subjects with tinea corporis, sponsored by Merz North America; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinea Corporis

Snippet

Sponsor: Merz North America, Inc. | Conditions: Tinea Corporis | Phase 4 | Status: COMPLETED